UnknownPhase 4NCT02535117

Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC

Studying Adult hepatocellular carcinoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sun Yat-sen University
Principal Investigator: Ming Kuang, Ph.D.
First Affiliated Hospital, Sun Yat-Sen University
Intervention: Laparoscopic Surgery(LS)(procedure)
Enrollment: 216 enrolled
Timeline: 2015 – 2020

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02535117 on ClinicalTrials.gov

Other trials for Adult hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONPHASE2NCT07441369
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
RECRUITINGPHASE2NCT07175441
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Riboscience, LLC.
RECRUITINGPHASE2NCT07560488
Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGPHASE1, PHASE2NCT07291076
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Bristol-Myers Squibb
RECRUITINGPHASE2NCT07010497
A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
Asan Medical Center
RECRUITINGPHASE1, PHASE2NCT07500220
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
Beijing Biotech
RECRUITINGPHASE2NCT07413354
Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma
Tongji Hospital
RECRUITINGNANCT07365527
Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases
Zealand University Hospital

See all trials for Adult hepatocellular carcinoma →

← Back to all trials